Related references
Note: Only part of the references are listed.Trimethylamine N-Oxide and Adenosine Diphosphate-Induced Platelet Reactivity Are Independent Risk Factors for Cardiovascular and All-Cause Mortality
Martin Berger et al.
CIRCULATION RESEARCH (2020)
Reasons for the Failure of Platelet Function Testing to Adjust Antiplatelet Therapy Pharmacodynamic Insights From the ARCTIC Study
Benoit Lattuca et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2019)
ADP Platelet Hyperreactivity Predicts Cardiovascular Disease in the FHS (Framingham Heart Study)
Marja K. Puurunen et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial
J. Michael Gaziano et al.
LANCET (2018)
Effect of Aspirin on All-Cause Mortality in the Healthy Elderly
J. J. McNeil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Aidin Rawshani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus
Louise Bowman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy JACC Guideline Comparison
Davide Capodanno et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study
Thomas Cuisset et al.
EUROPEAN HEART JOURNAL (2017)
Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial
Dirk Sibbing et al.
LANCET (2017)
Platelets Express Activated P2Y12 Receptor in Patients With Diabetes Mellitus
Liang Hu et al.
CIRCULATION (2017)
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Massimo F. Piepoli et al.
EUROPEAN HEART JOURNAL (2016)
Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised controlled superiority trial
Guillaume Cayla et al.
LANCET (2016)
High On-Treatment Platelet Reactivity as a Risk Factor for Secondary Prevention After Coronary Stent Revascularization A Landmark Analysis of the ARCTIC Study
Gilles Montalescot et al.
CIRCULATION (2014)
Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study
Gregg W. Stone et al.
LANCET (2013)
A measure of explained risk in the proportional hazards model
Glenn Heller
BIOSTATISTICS (2012)
A Randomized Trial of Prasugrel Versus Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stents Results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) Study
Dietmar Trenk et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Relationship between post-treatment platelet reactivity and ischemic and bleeding events at 1-year follow-up in patients receiving prasugrel
L. Bonello et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Bedside Monitoring to Adjust Antiplatelet Therapy for Coronary Stenting
Jean-Philippe Collet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention The GRAVITAS Randomized Trial
Matthew J. Price et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Prospective Evaluation of On-Clopidogrel Platelet Reactivity Over Time in Patients Treated With Percutaneous Coronary Intervention Relationship With Gene Polymorphisms and Clinical Outcome
Gianluca Campo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Adenosine diphosphate-induced platelet-fibrin clot strength: A new thrombelastographic indicator of long-term poststenting ischemic events
Paul A. Gurbel et al.
AMERICAN HEART JOURNAL (2010)
Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement
D. Sibbing et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Platelet α-granules: Basic biology and clinical correlates
Price Blair et al.
BLOOD REVIEWS (2009)
Platelet function monitoring in patients with coronary artery disease
Paul A. Gurbel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
ADP-induced platelet aggregation and platelet reactivity index VASP are good predictive markers for clinical outcomes in non-ST elevation acute coronary syndrome
Corinne Frere et al.
THROMBOSIS AND HAEMOSTASIS (2007)
PSGL-I regulates platelet P-selectin-mediated endothelial activation and shedding of P-selectin from activated platelets
Vandana S. Dole et al.
THROMBOSIS AND HAEMOSTASIS (2007)
Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention - The role of dual drug resistance
EI Lev et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Neonatal platelets from cord blood and peripheral blood
AG Sitaru et al.
PLATELETS (2005)
Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction
S Matetzky et al.
CIRCULATION (2004)
The adhesion molecule P-selectin and cardiovascular disease
AD Blann et al.
EUROPEAN HEART JOURNAL (2003)
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Course of platelet activation markers after ischemic stroke
L Marquardt et al.
STROKE (2002)
Share Paper
